IPERIONX LTD - ADR (IPX) Fundamental Analysis & Valuation

NASDAQ:IPX • US44916E1001

Current stock price

23.29 USD
-2 (-7.91%)
At close:
23.26 USD
-0.03 (-0.13%)
After Hours:

This IPX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. IPX Profitability Analysis

1.1 Basic Checks

  • IPX had negative earnings in the past year.
  • IPX had a negative operating cash flow in the past year.
  • In the past 5 years IPX always reported negative net income.
  • In the past 5 years IPX always reported negative operating cash flow.
IPX Yearly Net Income VS EBIT VS OCF VS FCFIPX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 -10M -20M -30M -40M

1.2 Ratios

  • IPX has a worse Return On Assets (-41.72%) than 86.62% of its industry peers.
  • IPX has a worse Return On Equity (-49.80%) than 79.62% of its industry peers.
Industry RankSector Rank
ROA -41.72%
ROE -49.8%
ROIC N/A
ROA(3y)-111.03%
ROA(5y)-168.25%
ROE(3y)-139.15%
ROE(5y)-240.98%
ROIC(3y)N/A
ROIC(5y)N/A
IPX Yearly ROA, ROE, ROICIPX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200 -200 -400 -600

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for IPX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
IPX Yearly Profit, Operating, Gross MarginsIPX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 -50K -100K -150K -200K -250K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. IPX Health Analysis

2.1 Basic Checks

  • IPX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • IPX has more shares outstanding than it did 1 year ago.
  • IPX has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, IPX has a worse debt to assets ratio.
IPX Yearly Shares OutstandingIPX Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
IPX Yearly Total Debt VS Total AssetsIPX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

2.2 Solvency

  • IPX has an Altman-Z score of 22.05. This indicates that IPX is financially healthy and has little risk of bankruptcy at the moment.
  • IPX has a Altman-Z score of 22.05. This is amongst the best in the industry. IPX outperforms 82.80% of its industry peers.
  • IPX has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
  • IPX's Debt to Equity ratio of 0.03 is fine compared to the rest of the industry. IPX outperforms 71.34% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z 22.05
ROIC/WACCN/A
WACC11.93%
IPX Yearly LT Debt VS Equity VS FCFIPX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M -40M 60M 80M

2.3 Liquidity

  • A Current Ratio of 4.03 indicates that IPX has no problem at all paying its short term obligations.
  • The Current ratio of IPX (4.03) is better than 75.80% of its industry peers.
  • IPX has a Quick Ratio of 4.00. This indicates that IPX is financially healthy and has no problem in meeting its short term obligations.
  • With a decent Quick ratio value of 4.00, IPX is doing good in the industry, outperforming 77.07% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.03
Quick Ratio 4
IPX Yearly Current Assets VS Current LiabilitesIPX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. IPX Growth Analysis

3.1 Past

  • IPX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -44.24%.
  • The Revenue for IPX has decreased by -100.00% in the past year. This is quite bad
  • Measured over the past years, IPX shows a very strong growth in Revenue. The Revenue has been growing by 78.65% on average per year.
EPS 1Y (TTM)-44.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-66.67%
Revenue 1Y (TTM)-100%
Revenue growth 3Y374.83%
Revenue growth 5Y78.65%
Sales Q2Q%-100%

3.2 Future

  • The Earnings Per Share is expected to grow by 60.53% on average over the next years. This is a very strong growth
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-24.18%
EPS Next 2Y21.54%
EPS Next 3Y31.76%
EPS Next 5Y60.53%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
IPX Yearly Revenue VS EstimatesIPX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 200M 400M 600M
IPX Yearly EPS VS EstimatesIPX Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 0 1 2 3

More info and screens

Find the best growth stocksShow best growing peers

1

4. IPX Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for IPX. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for IPX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IPX Price Earnings VS Forward Price EarningsIPX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IPX Per share dataIPX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3

4.3 Compensation for Growth

  • A more expensive valuation may be justified as IPX's earnings are expected to grow with 31.76% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y21.54%
EPS Next 3Y31.76%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. IPX Dividend Analysis

5.1 Amount

  • No dividends for IPX!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

IPX Fundamentals: All Metrics, Ratios and Statistics

IPERIONX LTD - ADR

NASDAQ:IPX (3/20/2026, 8:02:04 PM)

After market: 23.26 -0.03 (-0.13%)

23.29

-2 (-7.91%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)03-17
Earnings (Next)N/A
Inst Owners50.01%
Inst Owner Change110.33%
Ins Owners16.03%
Ins Owner ChangeN/A
Market Cap783.30M
Revenue(TTM)N/A
Net Income(TTM)-53.88M
Analysts80
Price Target46.41 (99.27%)
Short Float %2.37%
Short Ratio3.52
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-9.79%
PT rev (3m)25.45%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-22.33%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 7.24
P/tB 8.22
EV/EBITDA N/A
EPS(TTM)-1.64
EYN/A
EPS(NY)-0.42
Fwd EYN/A
FCF(TTM)-1.68
FCFYN/A
OCF(TTM)-0.8
OCFYN/A
SpS0
BVpS3.22
TBVpS2.83
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -41.72%
ROE -49.8%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-111.03%
ROA(5y)-168.25%
ROE(3y)-139.15%
ROE(5y)-240.98%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.03
Quick Ratio 4
Altman-Z 22.05
F-Score2
WACC11.93%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)909.1%
Cap/Sales(5y)2901.73%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-44.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-66.67%
EPS Next Y-24.18%
EPS Next 2Y21.54%
EPS Next 3Y31.76%
EPS Next 5Y60.53%
Revenue 1Y (TTM)-100%
Revenue growth 3Y374.83%
Revenue growth 5Y78.65%
Sales Q2Q%-100%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-67%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-6.67%
EBIT Next 3Y42.97%
EBIT Next 5Y66.14%
FCF growth 1Y-217.65%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-93.51%
OCF growth 3YN/A
OCF growth 5YN/A

IPERIONX LTD - ADR / IPX Fundamental Analysis FAQ

What is the ChartMill fundamental rating of IPERIONX LTD - ADR (IPX) stock?

ChartMill assigns a fundamental rating of 2 / 10 to IPX.


What is the valuation status of IPERIONX LTD - ADR (IPX) stock?

ChartMill assigns a valuation rating of 1 / 10 to IPERIONX LTD - ADR (IPX). This can be considered as Overvalued.


Can you provide the profitability details for IPERIONX LTD - ADR?

IPERIONX LTD - ADR (IPX) has a profitability rating of 0 / 10.


What is the financial health of IPERIONX LTD - ADR (IPX) stock?

The financial health rating of IPERIONX LTD - ADR (IPX) is 5 / 10.